1. Home
  2. COGT vs ODP Comparison

COGT vs ODP Comparison

Compare COGT & ODP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COGT
  • ODP
  • Stock Information
  • Founded
  • COGT 2014
  • ODP 1986
  • Country
  • COGT United States
  • ODP United States
  • Employees
  • COGT N/A
  • ODP N/A
  • Industry
  • COGT Biotechnology: Pharmaceutical Preparations
  • ODP Other Specialty Stores
  • Sector
  • COGT Health Care
  • ODP Consumer Discretionary
  • Exchange
  • COGT Nasdaq
  • ODP Nasdaq
  • Market Cap
  • COGT 545.3M
  • ODP 473.2M
  • IPO Year
  • COGT 2018
  • ODP N/A
  • Fundamental
  • Price
  • COGT $4.37
  • ODP $13.71
  • Analyst Decision
  • COGT Buy
  • ODP Hold
  • Analyst Count
  • COGT 7
  • ODP 1
  • Target Price
  • COGT $14.17
  • ODP $28.00
  • AVG Volume (30 Days)
  • COGT 1.7M
  • ODP 1.2M
  • Earning Date
  • COGT 05-06-2025
  • ODP 05-07-2025
  • Dividend Yield
  • COGT N/A
  • ODP N/A
  • EPS Growth
  • COGT N/A
  • ODP N/A
  • EPS
  • COGT N/A
  • ODP N/A
  • Revenue
  • COGT N/A
  • ODP $6,990,000,000.00
  • Revenue This Year
  • COGT N/A
  • ODP N/A
  • Revenue Next Year
  • COGT N/A
  • ODP N/A
  • P/E Ratio
  • COGT N/A
  • ODP $4.45
  • Revenue Growth
  • COGT N/A
  • ODP N/A
  • 52 Week Low
  • COGT $3.72
  • ODP $11.85
  • 52 Week High
  • COGT $12.61
  • ODP $52.69
  • Technical
  • Relative Strength Index (RSI)
  • COGT 34.56
  • ODP 46.38
  • Support Level
  • COGT $4.12
  • ODP $12.09
  • Resistance Level
  • COGT $5.09
  • ODP $13.64
  • Average True Range (ATR)
  • COGT 0.54
  • ODP 1.22
  • MACD
  • COGT -0.02
  • ODP 0.13
  • Stochastic Oscillator
  • COGT 23.90
  • ODP 57.76

About COGT Cogent Biosciences Inc.

Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.

About ODP The ODP Corporation

The ODP Corp operates an integrated B2B distribution platform with divisions focusing on various sectors: ODP Business Solutions serves small to enterprise-level companies with office supplies, technology, furniture, and services. Office Depot Division caters to retail consumers and small businesses through retail locations and eCommerce platforms, offering office supplies, technology, and business services. Veyer Division specializes in supply chain, distribution, and procurement services for both internal and third-party customers, with a focus on global operations. Varis Division offers a tech-enabled B2B indirect procurement marketplace, providing a seamless buying experience and advanced spend management tools. Revenue primarily stems from the Veyer division.

Share on Social Networks: